These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 23056634)
21. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Novak AJ; Grote DM; Stenson M; Ziesmer SC; Witzig TE; Habermann TM; Harder B; Ristow KM; Bram RJ; Jelinek DF; Gross JA; Ansell SM Blood; 2004 Oct; 104(8):2247-53. PubMed ID: 15251985 [TBL] [Abstract][Full Text] [Related]
22. TACI-Ig induces immune balance of Th cells in MLN via BLyS/APRIL-receptors signaling in rats with adjuvant-induced arthritis. Qin Q; Chang Y; Wang D; Wu Y; Zhang LL; Wei W Int Immunopharmacol; 2011 Dec; 11(12):2167-75. PubMed ID: 21996540 [TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS. Wu Y; Bressette D; Carrell JA; Kaufman T; Feng P; Taylor K; Gan Y; Cho YH; Garcia AD; Gollatz E; Dimke D; LaFleur D; Migone TS; Nardelli B; Wei P; Ruben SM; Ullrich SJ; Olsen HS; Kanakaraj P; Moore PA; Baker KP J Biol Chem; 2000 Nov; 275(45):35478-85. PubMed ID: 10956646 [TBL] [Abstract][Full Text] [Related]
24. Enhanced immunogenicity of pneumococcal surface adhesin A (PsaA) in mice via fusion to recombinant human B lymphocyte stimulator (BLyS). Gor DO; Ding X; Li Q; Sultana D; Mambula SS; Bram RJ; Greenspan NS Biol Direct; 2011 Feb; 6():9. PubMed ID: 21306646 [TBL] [Abstract][Full Text] [Related]
25. Selective killing of Burkitt's lymphoma cells by mBAFF-targeted delivery of PinX1. Zhang L; Jiang Y; Zheng Y; Zeng Y; Yang Z; Huang G; Liu D; Gao M; Shen X; Wu G; Yan X; He F Leukemia; 2011 Feb; 25(2):331-40. PubMed ID: 21102426 [TBL] [Abstract][Full Text] [Related]
26. BLyS expression and JNK activation may form a feedback loop to promote survival and proliferation of multiple myeloma cells. Xu G; Shen XJ; Pu J; Chu SP; Wang XD; Wu XH; Sun CJ; Zhang X; Zhu BL; Ju SQ Cytokine; 2012 Nov; 60(2):505-13. PubMed ID: 22850273 [TBL] [Abstract][Full Text] [Related]
27. Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclasts. Yaccoby S; Pennisi A; Li X; Dillon SR; Zhan F; Barlogie B; Shaughnessy JD Leukemia; 2008 Feb; 22(2):406-13. PubMed ID: 18046446 [TBL] [Abstract][Full Text] [Related]
28. Sortase-catalyzed in vitro functionalization of a HER2-specific recombinant Fab for tumor targeting of the plant cytotoxin gelonin. Kornberger P; Skerra A MAbs; 2014; 6(2):354-66. PubMed ID: 24492291 [TBL] [Abstract][Full Text] [Related]
29. Suppression of hepatoma tumor growth by systemic administration of the phytotoxin gelonin driven by the survivin promoter. Wang Z; Zhou X; Li J; Liu X; Chen Z; Shen G; Guan T; Ye N; Wei X; Huang N; Yang L; Wei Y; Li J Neoplasma; 2013; 60(5):469-79. PubMed ID: 23790164 [TBL] [Abstract][Full Text] [Related]
30. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders. Landau DA; Rosenzwajg M; Saadoun D; Klatzmann D; Cacoub P Ann Rheum Dis; 2009 Mar; 68(3):337-44. PubMed ID: 18434450 [TBL] [Abstract][Full Text] [Related]
31. The B Cell-Stimulatory Cytokines BLyS and APRIL Are Elevated in Human Periodontitis and Are Required for B Cell-Dependent Bone Loss in Experimental Murine Periodontitis. Abe T; AlSarhan M; Benakanakere MR; Maekawa T; Kinane DF; Cancro MP; Korostoff JM; Hajishengallis G J Immunol; 2015 Aug; 195(4):1427-35. PubMed ID: 26150532 [TBL] [Abstract][Full Text] [Related]
33. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. He B; Chadburn A; Jou E; Schattner EJ; Knowles DM; Cerutti A J Immunol; 2004 Mar; 172(5):3268-79. PubMed ID: 14978135 [TBL] [Abstract][Full Text] [Related]
34. [Expression and significance of BLyS/April in patients with acute idiopathic thrombocytopenic purpura]. Wang GB; Li CR; Li CG; Wang Y; Yang J Zhonghua Xue Ye Xue Za Zhi; 2008 Sep; 29(9):595-8. PubMed ID: 19175985 [TBL] [Abstract][Full Text] [Related]
36. An optimized B lymphocyte stimulator (BLyS) antagonist peptide inhibits the interaction of BLyS with BCMA. Tian Y; Zhu YF; Wu Z; Feng JN; Li Y; Shen BF; Sun J Biotechnol Lett; 2013 Apr; 35(4):523-8. PubMed ID: 23242501 [TBL] [Abstract][Full Text] [Related]
37. B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia. Elsawa SF; Novak AJ; Grote DM; Ziesmer SC; Witzig TE; Kyle RA; Dillon SR; Harder B; Gross JA; Ansell SM Blood; 2006 Apr; 107(7):2882-8. PubMed ID: 16304043 [TBL] [Abstract][Full Text] [Related]
38. Molecular tumor targeting of gelonin by fusion with F3 peptide. Ham SH; Min KA; Shin MC Acta Pharmacol Sin; 2017 Jun; 38(6):897-906. PubMed ID: 28414205 [TBL] [Abstract][Full Text] [Related]